Hydration Pharmaceuticals Company Ltd has released a press release.
Q1 FY24 Quarterly Activities Report (App 4C)
Filed with ASX ·
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Story so far
Earlier from Hydration Pharmaceuticals
- Waiver of ASX Listing Rule 10.1 Granted
- Variation to Facility Agreement with PURE Asset Management
- FY23 Appendix 4E
- Q4 FY23 Quarterly Activities Report (App 4C)
- Q3 FY23 Quarterly Activities Report (App 4C)
Later from Hydration Pharmaceuticals
- Q2 FY24 Quarterly Activities Report (App 4C)
- Appendix 4D and FY24 Half Year Financial Report
- FY24 Half Year Results Announcement
- Divesture of Hydralyte's non-US assets
- Completion of divesture of non-US assets
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals